Ann: Incannex to Acquire APIRx Pharmaceuticals, page-32

One of the most exciting announcements I've seen from IHL.

-$400bn addressable market
- Ease of delivery (chewing-gum); example of nicorette for nicotine addiction
-The connections that these guys have with medical schools in the US is not to be underestimated and the ability to roll-through IHL current programmes into the states will now be a lot easier given the exisiting realitonships. Similarly, for the experience their team has had dealign with FDA over there.

Great synergy in this one.